GTG.AX
Price:
$0.039
Market Cap:
$5.67M
Genetic Technologies Limited (GTG.AX), an Australian molecular diagnostics company founded in Fitzroy in 1987, delivers predictive genetic testing and risk assessment tools. These solutions empower medical professionals in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific to proactively manage patient health. The company operates through two distinct divisions: EasyDNA and GeneType/Corporate. Among its offerings is BREVAGenplus, a clinically validated test specifically designed for assessing the risk of non-hereditary breast cancer. This product is actively promoted to healthcare providers such as obstetricians/gynecologists, breast surgeons, and...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
1988-01-31
Stock Exchange
ASX
Ticker
GTG.AX
According to Genetic Technologies Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.66. This represents a change of 3.21% compared to the average of -0.64 of the last 4 quarters.
The mean historical PE Ratio of Genetic Technologies Limited over the last ten years is -3.60. The current -0.66 PE Ratio has changed 1.74% with respect to the historical average. Over the past ten years (40 quarters), GTG.AX's PE Ratio was at its highest in in the June 2011 quarter at 2.33K. The PE Ratio was at its lowest in in the June 2005 quarter at -4666.18.
Average
-3.60
Median
-3.26
Minimum
-10.27
Maximum
-0.89
Discovering the peaks and valleys of Genetic Technologies Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 207.97%
Maximum Annual PE Ratio = -0.89
Minimum Annual Increase = -96.19%
Minimum Annual PE Ratio = -10.27
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -0.89 | -57.23% |
| 2023 | -2.08 | -46.32% |
| 2022 | -3.88 | -62.19% |
| 2021 | -10.27 | 207.97% |
| 2020 | -3.33 | 17.35% |
| 2019 | -2.84 | -33.04% |
| 2018 | -4.24 | 159.74% |
| 2017 | -1.63 | -54.78% |
| 2016 | -3.61 | 13.49% |
| 2015 | -3.18 | -96.19% |
The current PE Ratio of Genetic Technologies Limited (GTG.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.29
5-year avg
-4.09
10-year avg
-3.60
Genetic Technologies Limited’s PE Ratio is less than Cann Global Limited (-0.63), greater than Opyl Limited (-6.91), less than Oventus Medical Limited (-0.32), greater than Medibio Limited (-11.69), less than Universal Biosensors, Inc. (-0.40), less than Bod Science Limited (16.00), less than Ecofibre Limited (-0.17), greater than Analytica Limited (-2.00), less than Visioneering Technologies, Inc. (-0.31), less than Freedom Care Group Holdings Ltd. (4.51),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.63 | $5.61M | |
| -6.91 | $5.41M | |
| -0.32 | $4.83M | |
| -11.69 | $4.55M | |
| -0.40 | $4.17M | |
| 16.00 | $4.26M | |
| -0.17 | $7.27M | |
| -2.00 | $4.61M | |
| -0.31 | $3.70M | |
| 4.51 | $4.01M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genetic Technologies Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Genetic Technologies Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Genetic Technologies Limited's PE Ratio?
How is the PE Ratio calculated for Genetic Technologies Limited (GTG.AX)?
What is the highest PE Ratio for Genetic Technologies Limited (GTG.AX)?
What is the 3-year average PE Ratio for Genetic Technologies Limited (GTG.AX)?
What is the 5-year average PE Ratio for Genetic Technologies Limited (GTG.AX)?
How does the current PE Ratio for Genetic Technologies Limited (GTG.AX) compare to its historical average?